DeepMed Research

Beijing Tsinghua Chang Gung Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Employees: -

Market Cap: -

Website: https://www.tsinghua.edu.cn/publish/chgen

Clinical Trials

CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.

Early Phase 1

Suspended

Conditions: B-cell Non-Hodgkin's Lymphoma

Interventions: Biological: CD19/CD20 Dual-CAR-T cells

First Posted Date: 2021-01-06

Last Posted Date: 2022-02-14

Lead Sponsor: Beijing Tsinghua Chang Gung Hospital

Target Recruit Count: 12

Registration Number: NCT04697290

Locations: 🇨🇳
Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China

Endovascular thromBectomy of Acute Mesentery Vessels Occlusion Hybrid With Emergent Laparoscopic Surgery

Completed

Conditions: Mesenteric Artery Ischemia
Thromboembolism

First Posted Date: 2020-12-29

Last Posted Date: 2024-03-21

Lead Sponsor: Beijing Tsinghua Chang Gung Hospital

Target Recruit Count: 42

Registration Number: NCT04686981

Locations: 🇨🇳
Beijing Tsinghua Chang Gung Hosipital, Beijing, Beijing, China

Clinical Study of Platelet-rich Plasma Promoting Tendon-bone Healing in Anterior Cruciate Ligament Reconstruction

Phase 1

Conditions: Sports Injury

Interventions: Drug: Platelet-Rich Plasma

First Posted Date: 2020-12-09

Last Posted Date: 2020-12-09

Lead Sponsor: Beijing Tsinghua Chang Gung Hospital

Target Recruit Count: 60

Registration Number: NCT04659447

Efficacy and Safety of Erector Spinal Plane Block (ESPB) for Analgesia in Laparoscopic Cholecystectomy

Not Applicable

Conditions: Analgesia

Interventions: Procedure: Erector spinal plane block

First Posted Date: 2020-12-01

Last Posted Date: 2020-12-01

Lead Sponsor: Beijing Tsinghua Chang Gung Hospital

Target Recruit Count: 90

Registration Number: NCT04648345

Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in Treatment of Huge Hepatocellular Carcinoma (HCC) (≥10cm)

Not Applicable

Conditions: Huge Hepatocellular Carcinoma (HCC) (≥10cm)

Interventions: Device: GSMs-TACE
Procedure: Surgical Resection

First Posted Date: 2020-11-06

Last Posted Date: 2020-11-30

Lead Sponsor: Beijing Tsinghua Chang Gung Hospital

Target Recruit Count: 78

Registration Number: NCT04619329

Locations: 🇨🇳
Beijing Tsinghua Changgung Hospital, Beijing, China

Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in the Treatment of Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT)

Not Applicable

Conditions: Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT)

Interventions: Device: GSMs-TACE
Procedure: Surgical Resection

First Posted Date: 2020-11-06

Last Posted Date: 2020-11-30

Lead Sponsor: Beijing Tsinghua Chang Gung Hospital

Target Recruit Count: 98

Registration Number: NCT04619342

Locations: 🇨🇳
Beijing Changgung Hospital, Beijing, China

Internet Technology Based Life-style and Care Intervention for Risk Factors of Non Communicable Diseases（NCD）

Not Applicable

Recruiting

Conditions: Lifestyle Intervention
Non Communicable Diseases

Interventions: Behavioral: Intensive intervention group
Behavioral: standard intervention group

First Posted Date: 2020-09-28

Last Posted Date: 2025-02-11

Lead Sponsor: Beijing Tsinghua Chang Gung Hospital

Target Recruit Count: 60000

Registration Number: NCT04567121

Locations: 🇨🇳
Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China

Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer

Phase 2

Conditions: Hepatocellular Carcinoma

Interventions: Drug: Camrelizumab Apatinib Mesylas

First Posted Date: 2020-08-21

Last Posted Date: 2020-08-21

Lead Sponsor: Beijing Tsinghua Chang Gung Hospital

Target Recruit Count: 27

Registration Number: NCT04523662

Risk Prediction of Difficult Tracheal Intubation in OSAHS Patient

Conditions: Difficult Intubation
Airway Obstruction

Interventions: Diagnostic Test: difficult tracheal intubation

First Posted Date: 2020-08-10

Last Posted Date: 2020-08-10

Lead Sponsor: Beijing Tsinghua Chang Gung Hospital

Target Recruit Count: 200

Registration Number: NCT04506346

Locations: 🇨🇳
YAN SIYI, Beijing, Beijing, China

GPC3-CAR-T Cells for the Hepatocellular Carcinoma

Phase 1

Suspended

Conditions: Hepatocellular Carcinoma

Interventions: Biological: GPC3-CAR-T cells

First Posted Date: 2020-08-10

Last Posted Date: 2022-02-14

Lead Sponsor: Beijing Tsinghua Chang Gung Hospital

Target Recruit Count: 12

Registration Number: NCT04506983

Locations: 🇨🇳
Beijing Tsinghua Changgung Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy